Copy Ml is a professional medical research chart displaying modified Intent-to-Treat (ITT) analysis data from a clinical study involving 58 patients. This comprehensive visualization tracks HIV viral load median changes (log₁₀ copies/mL) across five treatment combinations over a 43-day study period, with measurements taken at days 1, 3, 5, 8, 15, 29, and 43. The chart employs multiple line series to compare different dosage regimens of didanosine (ddl) combined with hydroxycarbamide (HC).
This analytical chart is essential for healthcare professionals, pharmaceutical researchers, clinical trial managers, and medical students who need to understand treatment efficacy and viral response patterns. It enables comparative analysis of different drug combinations and their impact on viral load reduction, making it invaluable for research presentations, medical publications, and clinical decision-making processes.
The chart includes five distinct treatment regimens: 200 mg ddl/300 mg HC, 200 mg ddl/600 mg HC, 400 mg ddl/800 mg HC, 400 mg ddl/300 mg HC, and 400 mg ddl/600 mg HC. The shaded treatment period indicates when study medications were administered, with clear tracking of viral load changes before, during, and after treatment cessation.
